The EIPR-1 antibody detects the EIPR1 protein (also known as TSSC1), which interacts with the Endosome-associated recycling protein (EARP) and Golgi-associated retrograde protein (GARP) complexes. These complexes mediate retrograde trafficking from endosomes to the trans-Golgi network (TGN) and plasma membrane . EIPR1 is essential for:
Validated applications include:
Commercial antibodies with peer-reviewed validation:
Loss of EIPR1 in insulinoma cells leads to:
EIPR1 co-immunoprecipitates with VPS51 (EARP) and VPS50 (GARP/EARP) in rat insulinoma cells .
CRISPR-mediated Eipr1 knockout destabilizes EARP subunits but not GARP .
C. elegans EIPR-1 mutants show defective DCV cargo sorting, phenocopying rab-2 pathway mutants .
WD40 domain of EIPR1 is critical for scaffolding EARP/GARP complexes across species .
Validation: KO/WT lysate comparisons are essential (e.g., loss of 45 kDa band in Eipr1 KO cells) .
Cross-Reactivity: Most antibodies target human EIPR1, but some (e.g., Invitrogen PA5-22360) cross-react with rat .
Localization: Antibodies should show punctate cytoplasmic staining overlapping with TGN38 or EARP markers .
Current studies focus on: